Does losartan lower blood sugar
Pro Research Analysisby 
Searched over 200M research papers
The Impact of Losartan on Blood Sugar Levels
Introduction to Losartan and Blood Sugar
Losartan, an angiotensin II receptor blocker (ARB), is primarily used to manage hypertension. However, its effects on blood sugar levels and glucose metabolism have been a subject of research, especially in patients with hypertension and diabetes. This article synthesizes findings from multiple studies to determine whether losartan lowers blood sugar levels.
Losartan and Glucose Metabolism
Neutral Effects on Glucose Metabolism
Several studies have shown that losartan has a neutral effect on glucose metabolism. In a study involving mildly hypertensive patients, losartan did not significantly alter glucose disposal rates or insulin responses during oral glucose tolerance tests (OGTT) compared to placebo . Similarly, another study found that losartan did not significantly change insulin sensitivity or glucose oxidation in hyperinsulinemic subjects with essential hypertension .
Improvement in Insulin Sensitivity
Contrary to the neutral findings, other research indicates that losartan can improve insulin sensitivity and glucose homeostasis. In patients with type 2 diabetes and nephropathy, losartan significantly decreased fasting blood glucose, HbA1c, and improved insulin sensitivity compared to the calcium channel blocker amlodipine . Additionally, losartan enhanced insulin-mediated glucose uptake and non-oxidative glucose metabolism in insulin-resistant hypertensive patients .
Risk of New-Onset Diabetes
Losartan has also been associated with a reduced risk of developing new-onset diabetes. In the LIFE study, hypertensive patients treated with losartan had a lower incidence of new-onset diabetes compared to those treated with atenolol . This suggests that losartan may have a protective effect against the development of diabetes in high-risk individuals.
Losartan and Hypoglycemia
Case of Severe Hypoglycemia
An interesting case report highlighted a non-diabetic patient who experienced severe hypoglycemia after starting losartan. The patient's blood sugar levels stabilized after discontinuing the medication, suggesting a potential link between losartan and hypoglycemia in certain individuals . This case underscores the need for careful monitoring of blood sugar levels in patients starting losartan, even if they do not have diabetes.
Conclusion
The effects of losartan on blood sugar levels and glucose metabolism are complex and can vary depending on the patient population. While some studies indicate that losartan has a neutral effect on glucose metabolism, others suggest it can improve insulin sensitivity and reduce the risk of new-onset diabetes. Additionally, there are rare cases where losartan may induce hypoglycemia in non-diabetic patients. Overall, losartan appears to have a generally positive or neutral impact on blood sugar levels, but individual responses may vary, necessitating personalized medical supervision.
Sources and full results
Most relevant research papers on this topic